At concentrations of 0.5–5 μM in NDM, CVM-A effectively inhibited cell survival by suppressing phosphorylation of Akt and mTOR—key mediators of cancer cell adaptation to metabolic stress. The gene discussed is AKT1; the disease is cancer.